文献速递胰腺与胆道疾病消化道肿瘤与早癌

慢性胰腺炎与胰腺癌风险:系统综述与荟萃分析

Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis.
PubMed 文献 · Am J Gastroenterol · 2017-08-01

该系统综述与荟萃分析纳入13项观察性研究,评估慢性胰腺炎与胰腺癌风险的关联强度及时间趋势。慢性胰腺炎患者胰腺癌总体效应估计值为16.16(95%CI:12.59-20.73),随随访时间延长风险逐渐降低,5年时效应估计值为7.90(95%CI:4.26-14.66)。作者建议慢性胰腺炎诊断后最初几年密切随访,并认为常用2年滞后期可能不足。

要点

  • 慢性胰腺炎患者胰腺癌总体效应估计值为16.16(95%CI:12.59-20.73)。
  • 随访5年时风险降至7.90(95%CI:4.26-14.66),至少9年时为3.53(95%CI:1.69-7.38)。
  • 作者建议慢性胰腺炎诊断后最初几年密切随访,并认为2年滞后期可能不足。

核心结论

  • 慢性胰腺炎增加胰腺癌风险,但随长期随访该关联减弱;诊断后5年慢性胰腺炎患者胰腺癌风险接近8倍。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE和EMBASE数据库中的观察性研究,共纳入13项符合条件的研究。

主要发现

  • 慢性胰腺炎患者胰腺癌总体效应估计值为16.16(95%CI:12.59-20.73)。
  • 慢性胰腺炎诊断后2年内诊断为胰腺癌的患者,合并效应估计值为16.16(95%CI:12.59-20.73)。
  • 滞后期延长至5年时,胰腺癌风险效应估计值为7.90(95%CI:4.26-14.66)。
  • 滞后期至少9年时,胰腺癌风险效应估计值为3.53(95%CI:1.69-7.38)。

关键数值与推荐

  • 慢性胰腺炎患者胰腺癌合并效应估计值为16.16(95%CI:12.59-20.73)。
  • 滞后期5年时效应估计值为7.90(95%CI:4.26-14.66)。
  • 滞后期至少9年时效应估计值为3.53(95%CI:1.69-7.38)。

临床怎么用

  • 作者建议慢性胰腺炎诊断后最初几年密切随访,以避免遗漏胰腺癌。
  • 作者认为这类研究中常用的2年滞后期可能不足。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic pancreatitis is a putative risk factor for pancreatic cancer. The aim of this study was to examine the magnitude and temporality of this association. We searched MEDLINE and EMBASE for observational studies investigating the association between chronic pancreatitis and pancreatic cancer. We computed overall effect estimates (EEs) with associated 95% confidence intervals (CIs) using a random-effects meta-analytic model. The EEs were stratified by length of follow-up from chronic pancreatitis diagnosis to pancreatic cancer (lag period). Robustness of the results was examined in sensitivity analyses. We identified 13 eligible studies. Pooled EEs for pancreatic cancer in patients with chronic pancreatitis were 16.16 (95% CI: 12.59-20.73) for patients diagnosed with pancreatic cancer within 2 years from their chronic pancreatitis diagnosis. The risk of pancreatic cancer in patients with chronic pancreatitis decreased when the lag period was increased to 5 years (EE: 7.90; 95% CI: 4.26-14.66) or a minimum of 9 years (EE: 3.53; 95% CI: 1.69-7.38). In conclusion, chronic pancreatitis increases the risk of pancreatic cancer, but the association diminishes with long-term follow-up. Five years after diagnosis, chronic pancreatitis patients have a nearly eight-fold increased risk of pancreatic cancer. We suggest that common practice on inducing a 2-year lag period in these studies may not be sufficient. We also recommend a close follow-up in the first years following a diagnosis of chronic pancreatitis to avoid overlooking a pancreatic cancer.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Kirkegård J, Mortensen FV, Cronin-Fenton D, et al. Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis. Am J Gastroenterol. 2017. PMID: 28762376. doi:10.1038/ajg.2017.218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。